Search results
Safer virus helps eliminate cancer in mouse study
Medical Xpress· 6 days agoThe attenuated virus—lymphocytic choriomeningitis virus (LCMV)—works and is safe even in immunosuppressed mice. "An important aspect about this viral-based therapy is that ...
Kairos Pharma, Ltd. Plans $6 Million IPO for Week of June 17th (KAPA)
ETF DAILY NEWS· 5 days agoKairos Pharma, Ltd. (KAPA) expects to raise $6 million in an initial public offering (IPO) on the...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan
Science Daily· 6 days agoScientists at St. Jude Children's Research Hospital and the University of Minnesota investigated the unique 'epigenetic clock' of T-cell aging, demonstrating ...
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL...
Morningstar· 3 days agoAmgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 9 hours agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
How Glowing Dye That Clings to Cancer Cells Gives Doctors ‘second pair of eyes’
GoodNewsNetwork· 4 days agoDeveloped for use in the removal of prostate cancer, the dye could be adapted to other cancers but...
Fate Therapeutics stock upgraded by Piper Sandler on autoimmune focus By Investing.com
Investing.com· 15 hours agoOn Monday, Piper Sandler shifted its stance on Fate Therapeutics (NASDAQ:FATE) stock, raising the...
Blackstone Inc. Makes New $7.89 Million Investment in Cabaletta Bio, Inc. (NASDAQ:CABA)
ETF DAILY NEWS· 5 days agoBlackstone Inc. bought a new stake in shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 347,494 shares of the company ...
Study: New type of psychotherapy helps treat chronic pain
UPI· 3 days agoA new form of psychotherapy appears to work even better at treating chronic pain in older adults...